[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Epiomic Epidemiology Series: Retinal Detachment Forecast in 18 Major Markets 2018–2028

January 2018 | 58 pages | ID: E029EE7C697EN
Black Swan Analysis limited

US$ 5,800.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Black Swan Analysis Epiomic Epidemiology Forecast Report on Retinal Detachment in 18 Major Markets

Retinal detachment (RD) is a condition in which the neurosensory retina (NSR), a layer of the retina composed of light-sensitive visual cells, separates from the retinal pigment epithelium (RPE). It is a serious condition potentially causing blindness, and one of the few ocular conditions requiring immediate medical intervention.

This report provides the current incident population for RD across 18 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current incidence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, subtypes of the condition, as well as several features of RD patients have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities of RD include:
  • High myopia
  • Inflammatory diseases (e.g., Vogt–Koyanagi–Harada syndrome, Behçet's disease)
  • Malignant and non-malignant retinal pathologies
  • Age-related macular degeneration
  • Choroidal neoplasms and metastases
  • Glaucoma
  • End-stage renal disease
  • Sickle-cell disease
  • Diabetes mellitus
  • Bacterial and viral infections / nematode infestations
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world-class sources that deliver the most up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy
  • Ability to quantify patient populations in global RD market to target the development of future products, pricing strategies and launch plans.
  • Further insight into the incidence of the subdivided types of RD and identification of patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Better understanding of the impact of specific co-morbid conditions on the incident population of RD patients.
  • Identification of RD patient sub-populations that require treatment.
  • Better understanding of the specific markets that have the largest number of RD patients.
INTRODUCTION

CAUSE OF THE DISEASE

RISK FACTORS & PREVENTION

DIAGNOSIS OF THE DISEASE

VARIATION BY GEOGRAPHY/ETHNICITY

DISEASE PROGNOSIS & CLINICAL COURSE

KEY COMORBID CONDITIONS / FEATURES ASSOCIATED WITH THE DISEASE

METHODOLOGY FOR QUANTIFICATION OF PATIENT NUMBERS

TOP-LINE INCIDENCE FOR RETINAL DETACHMENT

FEATURES OF RETINAL DETACHMENT PATIENTS

ABBREVIATIONS USED IN THE REPORT

OTHER BLACK SWAN SERVICES & SOLUTIONS

REPORTS & PUBLICATIONS

ONLINE EPIDEMIOLOGY DATABASES

ONLINE PHARMACEUTICAL PRICING DATABASE

REFERENCES

APPENDIX

LIST OF TABLES AND FIGURES

Table 1. Risk factors of retinal detachment
Table 2. Incidence of retinal detachment, total (000s)
Table 3. Incidence of retinal detachment, males (000s)
Table 4. Incidence of retinal detachment, females (000s)
Table 5. Patients with retinal detachment by type of disease, total (000s)
Table 6. Patients with retinal detachment by lens status, total (000s)
Table 7. Patients with retinal detachment by detachment type, total (000s)
Table 8. Patients with retinal detachment by history of cataract surgery, total (000s)
Table 9. Abbreviations and acronyms used in the report
Table 10. USA incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 11. USA incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 12. Canada incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 13. Canada incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 14. France incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 15. France incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 16. Germany incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 17. Germany incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 18. Italy incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 19. Italy incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 20. Spain incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 21. Spain incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 22. UK incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 23. UK incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 24. Poland incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 25. Poland incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 26. Netherlands incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 27. Netherlands incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 28. Turkey incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 29. Turkey incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 30. Japan incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 31. Japan incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 32. China incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 33. China incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 34. South Korea incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 35. South Korea incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 36. India incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 37. India incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 38. Australia incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 39. Australia incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 40. Brazil incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 41. Brazil incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 42. Mexico incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 43. Mexico incidence of retinal detachment by 5-yr age cohort, females (000s)
Table 44. Argentina incidence of retinal detachment by 5-yr age cohort, males (000s)
Table 45. Argentina incidence of retinal detachment by 5-yr age cohort, females (000s)
Figure 1. Histological cross-section of the retina with yellow dashed line indicating the site of detachment


More Publications